Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Breastfeeding and multiple sclerosis relapses: a meta-analysis.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Effirma, Synthetic Biologics
Sex hormones and multiple sclerosis: another informative failure.
European School of Neuroimmunology 15th Course
Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.
Differing trends in the incidence of vascular comorbidity in MS and the general population.
Mast cell inflammasome activity in the meninges regulates EAE disease severity.
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Development of a Bilingual MS-Specific Health Classification System: The Preference-Based Multiple Sclerosis Index.
Keystone Symposium: Mechanisms of Pro-Inflammatory Diseases - joint with - Innate Immunity and Determinants of Microbial Pathogenesis
Sleep and Cognitive Function in Multiple Sclerosis.
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Free MED IQ Live CME Event on Multiple Sclerosis Nov 22nd
Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis.
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
FOCIS Advanced Course in Basic and Clinical Immunology
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.

Pages